The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

Alberto Bardelli on what it’s like to ‘trend’ on Pubmed

June 26, 2018
Alberto Bardelli on what it’s like to ‘trend’ on Pubmed

PubMed is the leading search engine for biomedical literature, comprising more than 27 million citations for biomedical literature from MEDLINE, life science journals, and online books. 

PubMed has a page for “Trending articles” – PubMed records with a recent significant increase in views relative to baseline. Much like trending topics on social media, for an article to ‘trend’ on PubMed reflects a great surge of interest in the scientific community.


Trending: Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth

We spoke to EACR President Elect, Alberto Bardelli, about his lab’s recent Nature paper “Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth”, which was the number one trending article on PubMed for a significant period.


Why are the findings in the paper significant? (And how do you feel about it being the most popular paper on PubMed?)

The most exciting finding is the idea to turn an immune (cold) cancer into an immune (hot) one by triggering the emergence of neoantigens. If successful this strategy might, one day, lead to innovative therapies.

We were amazed to see that the paper has been continuously listed as the most Trending Article in PubMed, the main search engine for biomedical literature. PubMed contains over 27 million records (source: Wikipedia) and we are delighted that scientists worldwide found our results of interest and have shared the paper with others.

How long did it take from starting the research to it being published in Nature?

It took about three years, it was a long and complex journey as we sailed the uncharted waters of immunogenomics. Giovanni Germano,a young investigator and the first author of the study, worked relentlessly. The manuscript is largely the results of his dedication to science.

What is your lab working on now? (Is it directly based on the research in the paper, or have you moved on?)

The paper has opened up new avenues, and many lab members are following up on the Nature story. There are so many experiments we have designed and are presently ongoing! We are also engaging our clinical colleagues to see how we can best translate the new concepts in the clinical arena.


Find out more

Click here to access the Nature paper via PubMed: “Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth.”

Professor Bardelli’s lab at the Candiolo Cancer Institute – IRCCS

Tags: interviewpublicationpublish or perish

Related Posts

Beyond Pink October: From Early Detection to Precision Breast Cancer Care

Beyond Pink October: From Early Detection to Precision Breast Cancer Care

October 28, 2026

This article was written by EACR members Sabrina Dhooge (Argentina) and Dr. Motahareh Rezvan (Iran), who connected through the EACR Member Network. Both involved in breast...

“Being in a new lab environment allowed me to broaden my research expertise”: Virginia Maini’s Travel Fellowship

“Being in a new lab environment allowed me to broaden my research expertise”: Virginia Maini’s Travel Fellowship

October 26, 2026

Virginia Maini is a PhD student at the European Institute of Oncology (IEO), Italy, who received an EACR Travel Fellowship to visit and work at the...

Magdalena Sznurkowska’s EACR-AstraZeneca Postdoctoral Fellowship – Final Report

Magdalena Sznurkowska’s EACR-AstraZeneca Postdoctoral Fellowship – Final Report

October 12, 2026

Magdalena Sznurkowska was the 2024 recipient of an EACR-AstraZeneca Postdoctoral Fellowship, funding that is awarded for a period of up to three years to support excellent...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

Advertisement Advertisement Advertisement
ADVERTISEMENT

RECENT POSTS

Beyond Pink October: From Early Detection to Precision Breast Cancer Care
Career

Beyond Pink October: From Early Detection to Precision Breast Cancer Care

October 28, 2026
“Being in a new lab environment allowed me to broaden my research expertise”: Virginia Maini’s Travel Fellowship
Career

“Being in a new lab environment allowed me to broaden my research expertise”: Virginia Maini’s Travel Fellowship

October 26, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR